About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A Study to Explore the Role of Gut Flora in ALS | Clinical Trials | Clareo Health

Back to clinical trial search

WITHDRAWNNCT04150809

A Study to Explore the Role of Gut Flora in ALS

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding ALS

Lead sponsor: ProgenaBiome•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

ProgenaBiome

The goal of this Research Study is to better understand how the genetic information in subject's microbiome correlates to the information provided in surveys and in medical records regarding ALS

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study
•2. Male or female patients of any age (interest is given to children to compare with mothers).
•3. Diagnosis of ALS

Exclusion Criteria

•1. Refusal to sign informed consent form
•2. History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
•3. Postoperative stoma, ostomy, or ileoanal pouch
•4. Participation in any experimental drug protocol within the past 12 weeks
•5. Treatment with total parenteral nutrition
•6. Any clinically significant evidence of disease that could interfere with the subject's ability to enter the trial
•7. Inability to adequately communicate with the investigator or their respective designee and/or comply with the requirements of the entire study

Related studies

Constraint-induced Movement Therapy Combined With Functional Electrical Stimulation in Children With Cerebral Palsy

NCT07587476 · Cerebral Palsy (CP)

Ultra-high-caloric, Fatty Diet in ALS

NCT06280079 · Amyotrophic Lateral Sclerosis

Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients

NCT06051123 · ALSFTD, ALS (Amyotrophic Lateral Sclerosis), and more

Cerebral Palsy and the Study of Brain Activity During Motor Tasks

NCT01829724 · Cerebral Palsy, Children

Investigating New Methods to Study Movement in Children and Young Adults With Movement Disorders.

NCT06498596 · Cerebral Palsy

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 5, 2025Terms

Trial snapshot

StatusWITHDRAWN

Phase—

Enrollment—

Start dateMar 2020

Last updatedJun 5, 2025

Condition

ALS Amyotrophic Lateral Sclerosis Motor Neuron Disease

Locations shown

ProgenaBiome

Ventura, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 5, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions